494 related articles for article (PubMed ID: 35324673)
1. Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective.
Lohia S; Vlahou A; Zoidakis J
Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324673
[TBL] [Abstract][Full Text] [Related]
2. Homeostasis in the Gut Microbiota in Chronic Kidney Disease.
Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917
[TBL] [Abstract][Full Text] [Related]
3. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
4. The clinical impact of gut microbiota in chronic kidney disease.
Kim SM; Song IH
Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
[TBL] [Abstract][Full Text] [Related]
5. Uremic Toxin-Producing
Shivani S; Kao CY; Chattopadhyay A; Chen JW; Lai LC; Lin WH; Lu TP; Huang IH; Tsai MH; Teng CH; Wu JJ; Hsieh YH; Wang MC; Chuang EY
Front Cell Infect Microbiol; 2022; 12():726256. PubMed ID: 35558102
[TBL] [Abstract][Full Text] [Related]
6. Microbiome modulation to correct uremic toxins and to preserve kidney functions.
Caggiano G; Cosola C; Di Leo V; Gesualdo M; Gesualdo L
Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):49-56. PubMed ID: 31725010
[TBL] [Abstract][Full Text] [Related]
7. Link between gut microbiota dysbiosis and chronic kidney disease.
Noce A; Marchetti M; Marrone G; Di Renzo L; Di Lauro M; Di Daniele F; Albanese M; Di Daniele N; De Lorenzo A
Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2057-2074. PubMed ID: 35363356
[TBL] [Abstract][Full Text] [Related]
8. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial.
Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome in chronic kidney disease: challenges and opportunities.
Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
[TBL] [Abstract][Full Text] [Related]
10. Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: target for treatment of gut dysbiosis in chronic kidney disease? From current evidence to future possibilities.
Coutinho-Wolino KS; Melo MFS; Mota JC; Mafra D; Guimarães JT; Stockler-Pinto MB
Nutr Rev; 2024 Jan; 82(2):248-261. PubMed ID: 37164634
[TBL] [Abstract][Full Text] [Related]
11. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
12. Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease.
Yang CY; Chen TW; Lu WL; Liang SS; Huang HD; Tseng CP; Tarng DC
Cells; 2021 Jan; 10(1):. PubMed ID: 33435396
[TBL] [Abstract][Full Text] [Related]
13. Lanthanum hydroxide protects kidney through gut microbiota in a rat model of chronic kidney disease.
Gao Y; Wang S; Sun L; Li B; Liu H; Bu R; Su C; Guo M; Liu Y; Zhao L; Gu C; Li X; Yuan X; Wang Q; Li G
Pharmacol Res Perspect; 2024 Apr; 12(2):e1187. PubMed ID: 38546116
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.
Taguchi K; Fukami K; Elias BC; Brooks CR
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069405
[TBL] [Abstract][Full Text] [Related]
15. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
[TBL] [Abstract][Full Text] [Related]
16. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
[TBL] [Abstract][Full Text] [Related]
17. Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease.
Wu IW; Gao SS; Chou HC; Yang HY; Chang LC; Kuo YL; Dinh MCV; Chung WH; Yang CW; Lai HC; Hsieh WP; Su SC
Theranostics; 2020; 10(12):5398-5411. PubMed ID: 32373220
[TBL] [Abstract][Full Text] [Related]
18. Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?
Hsu CN; Tain YL
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409313
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
[TBL] [Abstract][Full Text] [Related]
20. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
